药物信息为Levetiracetam Tablets (Caremark L.L.C.): DESCRIPTION
- DESCRIPTION
- Mechanism Of Action
- Pharmacokinetics
- Overview
- Absorption and Distribution
- Metabolism
- Elimination
- Pharmacokinetic Interactions
- Elderly
- Pediatric Patients
- Gender
- Race
- Renal Impairment
- Hepatic Impairment
- CLINICAL STUDIES
- Effectiveness In Partial Onset Seizures in Adults With Epilepsy
- Study 1
- Study 2
- Study 3
- Effectiveness In Partial Onset Seizures In Pediatric Patients With Epilepsy
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- Suicidal Behavior and Ideation
- Adults
- Pediatric Patients
- Withdrawal Seizures
- Adults
- Pediatric Patients
- Hepatic Abnormalities
- Information for Patients
- Laboratory Tests
- Drug Interactions
- Phenytoin
- Valproate
- Effect of AEDs in Pediatric Patients
- Oral Contraceptives
- Digoxin
- Warfarin
- Probenecid
- Carcinogenesis
- Mutagenesis
- Impairment of Fertility
- Pregnancy Category C
- Pregnancy Registries
- Labor and Delivery
- Nursing Mothers
- Pediatric Use
- Geriatric Use
- Use in Patients With Impaired Renal Function
- ADVERSE REACTIONS
- Partial Onset Seizures
- Time Course Of Onset Of Adverse Events For Partial Onset Seizures
- Partial Onset Seizures
- Comparison Of Gender, Age And Race
- Postmarketing Experience
- DRUG ABUSE AND DEPENDENCE
- Signs, Symptoms And Laboratory Findings Of Acute Overdosage in Humans
- Treatment Or Management Of Overdose
- Hemodialysis
- DOSAGE AND ADMINISTRATION
- Adults 16 Years and Older
- Pediatric Patients Ages 4 To <16 Years
- Adult Patients With Impaired Renal Function
- HOW SUPPLIED
- Storage
- Levetiracetam Tablets
- What is the most important information I should know about levetiracetam?
- How can I watch for early symptoms of suicidal thoughts and actions?
- What is levetiracetam?
- What should I tell my healthcare provider before starting levetiracetam?
- How should I take levetiracetam?
- What should I avoid while taking levetiracetam?
- What are the possible side effects of levetiracetam?
- How should I store levetiracetam?
- General information about levetiracetam
- What are the ingredients of levetiracetam?
- Manufacturer Information
- 外部链接相关的Levetiracetam Tablets (Caremark L.L.C.)
Levetiracetam is an antiepileptic drug available as 250 mg (blue), 500 mg (yellow), 750 mg (light beige) and 1000 mg (white) tablets for oral administration.
The chemical name of levetiracetam, a single enantiomer, is ()(S)aethyl2oxo1-pyrrolidine acetamide, its molecular formula is C8H14N2O2 and its molecular weight is 170.21. Levetiracetam is chemically unrelated to existing antiepileptic drugs (AEDs). It has the following structural formula:

Levetiracetam is a white to off-white crystalline powder with a faint odor and a bitter taste. It is very soluble in water (104 g/100 mL). It is freely soluble in chloroform (65.3 g/100 mL) and in methanol (53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble in acetonitrile (5.7 g/100 mL) and practically insoluble in nhexane. (Solubility limits are expressed as g/100 mL solvent.)
Levetiracetam Tablets contain the labeled amount of levetiracetam. Inactive ingredients: colloidal silicon dioxide, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, and modified cellulose gum. In addition to the ingredients listed above, the 250 mg tablet contains Opadry II (Blue), the 500 mg tablet contains Opadry II (Yellow), the 750 mg tablet contains Opadry II (Flesh) and the 1000 mg tablet contains Opadry II (white). Opadry II (Blue) contains FD&C Blue #2, hypromellose, macrogol, polydextrose, titanium dioxide, and triacetin. Opadry II (Yellow) contains hypromellose, iron oxide yellow, macrogol, polydextrose, titanium dioxide, and triacetin. Opadry II (Flesh) contains hypromellose, iron oxide yellow, iron oxide red, macrogol, polydextrose, titanium dioxide, and triacetin. Opadry II (white) contains hypromellose, polyethylene glycol, polydextrose, titanium dioxide, and triacetin.
- Drug Information Provided by National Library of Medicine (NLM).
